Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Clinical Trial Imaging Market by Product Services (Software, Services), by Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, Other Modalities) and by End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes, Other End-Users): Global Opportunity Analysis and Industry Forecast, 2023-2032

A01678

Pages: NA

Charts: NA

Tables: NA

Clinical trials are an important part of the drug development process. However, the cost of conducting clinical trials has increased in the recent years. Therefore, clinical trial imaging is emerging as an alternative measure which can help reduce the cost of drug trial and thus improve the timeline of clinical trials.

The global clinical trial imaging market is expected to witness significant growth during the forecast period due to increased spending for research and development, and increasing number of pharmaceutical and biotechnological industries. In addition, increasing number of contract research organizations has further boosted the market growth. However, high cost of the imaging systems hampers the market growth.

The clinical trial imaging market is segmented based on product and services, modality, end-user, and region. Based on product and services, the market is segmented into service and software. On the basis of modality, the clinical trial imaging market is broadly classified into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, x-ray, echocardiography, and other modalities. On the basis of end-user, the market is categorized into pharmaceutical companies, biotechnology companies, medical device manufacturers, contract research organizations, academic and government research institutes, and other end-users. The market is analyzed based on four geographical regions, which include North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include Parexel International Corporation, Biomedical Systems Corporation, Biotelemetry, Inc., Cardiovascular Imaging Technologies LLC, Intrinsic Imaging LLC, Radiant Sage LLC, and Worldcare Clinical, LLC.

Key Benefits for Stakeholders

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global clinical trial imagingmarket.
  • Comprehensive analysis of regions is provided to determine the prevailing opportunities in the global market.
  • This study provides the competitive landscape of the global market to predict the competitive environment across geographies.
  • This report entails the detailed quantitative analysis of the current market and estimations to identify the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.
  • Region- and country-wise clinical trial imagingmarket conditions are comprehensively analyzed in the report to understand the regional trends and dynamics.

 Key Market Segments

  • By Product & Services
    • Software
    • Services
  • By Modality
    • Computed Tomography
    • Magnetic Resonance Imaging
    • Ultrasound
    • Positron Emission Tomography
    • X-Ray
    • Echocardiography
    • Other Modalities
  • By End-User
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Medical Device Manufacturers
    • Contract Research Organizations
    • Academic and Government Research Institutes
    • Other End-Users
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Biotelemetry, Inc.
  • Intrinsic Imaging LLC
  • Cardiovascular Imaging Technologies LLC
  • Parexel International Corporation
  • Worldcare Clinical, LLC.
  • Biomedical Systems Corporation
  • Radiant Sage LLC

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: CLINICAL TRIAL IMAGING MARKET, BY PRODUCT AND SERVICES

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product And Services

    • 4.2. Software

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Services

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: CLINICAL TRIAL IMAGING MARKET, BY MODALITY

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Modality

    • 5.2. Computed Tomography

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Magnetic Resonance Imaging

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ultrasound

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Positron Emission Tomography

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. X-Ray

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Echocardiography

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Other Modalities

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: CLINICAL TRIAL IMAGING MARKET, BY END-USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End-user

    • 6.2. Pharmaceutical Companies

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Biotechnology Companies

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Medical Device Manufacturers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Contract Research Organizations

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Academic And Government Research Institutes

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

    • 6.7. Other End-Users

      • 6.7.1. Key Market Trends, Growth Factors and Opportunities

      • 6.7.2. Market Size and Forecast, By Region

      • 6.7.3. Market Share Analysis, By Country

  • CHAPTER 7: CLINICAL TRIAL IMAGING MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product And Services

      • 7.2.3. Market Size and Forecast, By Modality

      • 7.2.4. Market Size and Forecast, By End-user

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Clinical Trial Imaging Market

        • 7.2.6.1. Market Size and Forecast, By Product And Services
        • 7.2.6.2. Market Size and Forecast, By Modality
        • 7.2.6.3. Market Size and Forecast, By End-user

      • 7.2.7. Canada Clinical Trial Imaging Market

        • 7.2.7.1. Market Size and Forecast, By Product And Services
        • 7.2.7.2. Market Size and Forecast, By Modality
        • 7.2.7.3. Market Size and Forecast, By End-user

      • 7.2.8. Mexico Clinical Trial Imaging Market

        • 7.2.8.1. Market Size and Forecast, By Product And Services
        • 7.2.8.2. Market Size and Forecast, By Modality
        • 7.2.8.3. Market Size and Forecast, By End-user

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product And Services

      • 7.3.3. Market Size and Forecast, By Modality

      • 7.3.4. Market Size and Forecast, By End-user

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Clinical Trial Imaging Market

        • 7.3.6.1. Market Size and Forecast, By Product And Services
        • 7.3.6.2. Market Size and Forecast, By Modality
        • 7.3.6.3. Market Size and Forecast, By End-user

      • 7.3.7. Germany Clinical Trial Imaging Market

        • 7.3.7.1. Market Size and Forecast, By Product And Services
        • 7.3.7.2. Market Size and Forecast, By Modality
        • 7.3.7.3. Market Size and Forecast, By End-user

      • 7.3.8. Italy Clinical Trial Imaging Market

        • 7.3.8.1. Market Size and Forecast, By Product And Services
        • 7.3.8.2. Market Size and Forecast, By Modality
        • 7.3.8.3. Market Size and Forecast, By End-user

      • 7.3.9. Spain Clinical Trial Imaging Market

        • 7.3.9.1. Market Size and Forecast, By Product And Services
        • 7.3.9.2. Market Size and Forecast, By Modality
        • 7.3.9.3. Market Size and Forecast, By End-user

      • 7.3.10. UK Clinical Trial Imaging Market

        • 7.3.10.1. Market Size and Forecast, By Product And Services
        • 7.3.10.2. Market Size and Forecast, By Modality
        • 7.3.10.3. Market Size and Forecast, By End-user

      • 7.3.11. Russia Clinical Trial Imaging Market

        • 7.3.11.1. Market Size and Forecast, By Product And Services
        • 7.3.11.2. Market Size and Forecast, By Modality
        • 7.3.11.3. Market Size and Forecast, By End-user

      • 7.3.12. Rest Of Europe Clinical Trial Imaging Market

        • 7.3.12.1. Market Size and Forecast, By Product And Services
        • 7.3.12.2. Market Size and Forecast, By Modality
        • 7.3.12.3. Market Size and Forecast, By End-user

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product And Services

      • 7.4.3. Market Size and Forecast, By Modality

      • 7.4.4. Market Size and Forecast, By End-user

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Clinical Trial Imaging Market

        • 7.4.6.1. Market Size and Forecast, By Product And Services
        • 7.4.6.2. Market Size and Forecast, By Modality
        • 7.4.6.3. Market Size and Forecast, By End-user

      • 7.4.7. Japan Clinical Trial Imaging Market

        • 7.4.7.1. Market Size and Forecast, By Product And Services
        • 7.4.7.2. Market Size and Forecast, By Modality
        • 7.4.7.3. Market Size and Forecast, By End-user

      • 7.4.8. India Clinical Trial Imaging Market

        • 7.4.8.1. Market Size and Forecast, By Product And Services
        • 7.4.8.2. Market Size and Forecast, By Modality
        • 7.4.8.3. Market Size and Forecast, By End-user

      • 7.4.9. South Korea Clinical Trial Imaging Market

        • 7.4.9.1. Market Size and Forecast, By Product And Services
        • 7.4.9.2. Market Size and Forecast, By Modality
        • 7.4.9.3. Market Size and Forecast, By End-user

      • 7.4.10. Australia Clinical Trial Imaging Market

        • 7.4.10.1. Market Size and Forecast, By Product And Services
        • 7.4.10.2. Market Size and Forecast, By Modality
        • 7.4.10.3. Market Size and Forecast, By End-user

      • 7.4.11. Thailand Clinical Trial Imaging Market

        • 7.4.11.1. Market Size and Forecast, By Product And Services
        • 7.4.11.2. Market Size and Forecast, By Modality
        • 7.4.11.3. Market Size and Forecast, By End-user

      • 7.4.12. Malaysia Clinical Trial Imaging Market

        • 7.4.12.1. Market Size and Forecast, By Product And Services
        • 7.4.12.2. Market Size and Forecast, By Modality
        • 7.4.12.3. Market Size and Forecast, By End-user

      • 7.4.13. Indonesia Clinical Trial Imaging Market

        • 7.4.13.1. Market Size and Forecast, By Product And Services
        • 7.4.13.2. Market Size and Forecast, By Modality
        • 7.4.13.3. Market Size and Forecast, By End-user

      • 7.4.14. Rest of Asia Pacific Clinical Trial Imaging Market

        • 7.4.14.1. Market Size and Forecast, By Product And Services
        • 7.4.14.2. Market Size and Forecast, By Modality
        • 7.4.14.3. Market Size and Forecast, By End-user

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product And Services

      • 7.5.3. Market Size and Forecast, By Modality

      • 7.5.4. Market Size and Forecast, By End-user

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Clinical Trial Imaging Market

        • 7.5.6.1. Market Size and Forecast, By Product And Services
        • 7.5.6.2. Market Size and Forecast, By Modality
        • 7.5.6.3. Market Size and Forecast, By End-user

      • 7.5.7. South Africa Clinical Trial Imaging Market

        • 7.5.7.1. Market Size and Forecast, By Product And Services
        • 7.5.7.2. Market Size and Forecast, By Modality
        • 7.5.7.3. Market Size and Forecast, By End-user

      • 7.5.8. Saudi Arabia Clinical Trial Imaging Market

        • 7.5.8.1. Market Size and Forecast, By Product And Services
        • 7.5.8.2. Market Size and Forecast, By Modality
        • 7.5.8.3. Market Size and Forecast, By End-user

      • 7.5.9. UAE Clinical Trial Imaging Market

        • 7.5.9.1. Market Size and Forecast, By Product And Services
        • 7.5.9.2. Market Size and Forecast, By Modality
        • 7.5.9.3. Market Size and Forecast, By End-user

      • 7.5.10. Argentina Clinical Trial Imaging Market

        • 7.5.10.1. Market Size and Forecast, By Product And Services
        • 7.5.10.2. Market Size and Forecast, By Modality
        • 7.5.10.3. Market Size and Forecast, By End-user

      • 7.5.11. Rest of LAMEA Clinical Trial Imaging Market

        • 7.5.11.1. Market Size and Forecast, By Product And Services
        • 7.5.11.2. Market Size and Forecast, By Modality
        • 7.5.11.3. Market Size and Forecast, By End-user

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Parexel International Corporation

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Biomedical Systems Corporation

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Biotelemetry, Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Cardiovascular Imaging Technologies LLC

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Intrinsic Imaging LLC

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Radiant Sage LLC

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Worldcare Clinical, LLC.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL TRIAL IMAGING MARKET, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR SOFTWARE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR SERVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL IMAGING MARKET, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR ULTRASOUND, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR POSITRON EMISSION TOMOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR X-RAY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR ECHOCARDIOGRAPHY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR OTHER MODALITIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL IMAGING MARKET, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL IMAGING MARKET FOR OTHER END-USERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL IMAGING MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA CLINICAL TRIAL IMAGING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 22. NORTH AMERICA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 23. NORTH AMERICA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 24. U.S. CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 25. U.S. CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 26. U.S. CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 27. CANADA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 28. CANADA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 29. CANADA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 30. MEXICO CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 31. MEXICO CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 32. MEXICO CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE CLINICAL TRIAL IMAGING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 34. EUROPE CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 35. EUROPE CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 36. EUROPE CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 37. FRANCE CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 38. FRANCE CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 39. FRANCE CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 40. GERMANY CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 41. GERMANY CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 42. GERMANY CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 43. ITALY CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 44. ITALY CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 45. ITALY CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 46. SPAIN CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 47. SPAIN CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 48. SPAIN CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 49. UK CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 50. UK CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 51. UK CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 52. RUSSIA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 53. RUSSIA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 54. RUSSIA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 55. REST OF EUROPE CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 56. REST OF EUROPE CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 57. REST OF EUROPE CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC CLINICAL TRIAL IMAGING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 59. ASIA-PACIFIC CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 60. ASIA-PACIFIC CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 61. ASIA-PACIFIC CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 62. CHINA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 63. CHINA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 64. CHINA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 65. JAPAN CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 66. JAPAN CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 67. JAPAN CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 68. INDIA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 69. INDIA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 70. INDIA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 71. SOUTH KOREA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 72. SOUTH KOREA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 73. SOUTH KOREA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 74. AUSTRALIA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 75. AUSTRALIA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 76. AUSTRALIA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 77. THAILAND CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 78. THAILAND CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 79. THAILAND CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 80. MALAYSIA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 81. MALAYSIA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 82. MALAYSIA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 83. INDONESIA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 84. INDONESIA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 85. INDONESIA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 87. REST OF ASIA PACIFIC CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 88. REST OF ASIA PACIFIC CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA CLINICAL TRIAL IMAGING, BY REGION, 2025-2033 ($MILLION)
  • TABLE 90. LAMEA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 91. LAMEA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 92. LAMEA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 93. BRAZIL CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 94. BRAZIL CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 95. BRAZIL CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 96. SOUTH AFRICA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 97. SOUTH AFRICA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 98. SOUTH AFRICA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 99. SAUDI ARABIA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 100. SAUDI ARABIA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 101. SAUDI ARABIA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 102. UAE CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 103. UAE CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 104. UAE CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 105. ARGENTINA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 106. ARGENTINA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 107. ARGENTINA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 108. REST OF LAMEA CLINICAL TRIAL IMAGING, BY PRODUCT AND SERVICES, 2025-2033 ($MILLION)
  • TABLE 109. REST OF LAMEA CLINICAL TRIAL IMAGING, BY MODALITY, 2025-2033 ($MILLION)
  • TABLE 110. REST OF LAMEA CLINICAL TRIAL IMAGING, BY END-USER, 2025-2033 ($MILLION)
  • TABLE 111. PAREXEL INTERNATIONAL CORPORATION: KEY EXECUTIVES
  • TABLE 112. PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 113. PAREXEL INTERNATIONAL CORPORATION: OPERATING SEGMENTS
  • TABLE 114. PAREXEL INTERNATIONAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. PAREXEL INTERNATIONAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. BIOMEDICAL SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 117. BIOMEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 118. BIOMEDICAL SYSTEMS CORPORATION: OPERATING SEGMENTS
  • TABLE 119. BIOMEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 120. BIOMEDICAL SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. BIOTELEMETRY, INC.: KEY EXECUTIVES
  • TABLE 122. BIOTELEMETRY, INC.: COMPANY SNAPSHOT
  • TABLE 123. BIOTELEMETRY, INC.: OPERATING SEGMENTS
  • TABLE 124. BIOTELEMETRY, INC.: PRODUCT PORTFOLIO
  • TABLE 125. BIOTELEMETRY, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126. CARDIOVASCULAR IMAGING TECHNOLOGIES LLC: KEY EXECUTIVES
  • TABLE 127. CARDIOVASCULAR IMAGING TECHNOLOGIES LLC: COMPANY SNAPSHOT
  • TABLE 128. CARDIOVASCULAR IMAGING TECHNOLOGIES LLC: OPERATING SEGMENTS
  • TABLE 129. CARDIOVASCULAR IMAGING TECHNOLOGIES LLC: PRODUCT PORTFOLIO
  • TABLE 130. CARDIOVASCULAR IMAGING TECHNOLOGIES LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 131. INTRINSIC IMAGING LLC: KEY EXECUTIVES
  • TABLE 132. INTRINSIC IMAGING LLC: COMPANY SNAPSHOT
  • TABLE 133. INTRINSIC IMAGING LLC: OPERATING SEGMENTS
  • TABLE 134. INTRINSIC IMAGING LLC: PRODUCT PORTFOLIO
  • TABLE 135. INTRINSIC IMAGING LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 136. RADIANT SAGE LLC: KEY EXECUTIVES
  • TABLE 137. RADIANT SAGE LLC: COMPANY SNAPSHOT
  • TABLE 138. RADIANT SAGE LLC: OPERATING SEGMENTS
  • TABLE 139. RADIANT SAGE LLC: PRODUCT PORTFOLIO
  • TABLE 140. RADIANT SAGE LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 141. WORLDCARE CLINICAL, LLC.: KEY EXECUTIVES
  • TABLE 142. WORLDCARE CLINICAL, LLC.: COMPANY SNAPSHOT
  • TABLE 143. WORLDCARE CLINICAL, LLC.: OPERATING SEGMENTS
  • TABLE 144. WORLDCARE CLINICAL, LLC.: PRODUCT PORTFOLIO
  • TABLE 145. WORLDCARE CLINICAL, LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CLINICAL TRIAL IMAGING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CLINICAL TRIAL IMAGING MARKET
  • FIGURE 3. SEGMENTATION CLINICAL TRIAL IMAGING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CLINICAL TRIAL IMAGING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCLINICAL TRIAL IMAGING MARKET
  • FIGURE 11. CLINICAL TRIAL IMAGING MARKET SEGMENTATION, BY BY PRODUCT AND SERVICES
  • FIGURE 12. CLINICAL TRIAL IMAGING MARKET FOR SOFTWARE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. CLINICAL TRIAL IMAGING MARKET FOR SERVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. CLINICAL TRIAL IMAGING MARKET SEGMENTATION, BY BY MODALITY
  • FIGURE 15. CLINICAL TRIAL IMAGING MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. CLINICAL TRIAL IMAGING MARKET FOR MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. CLINICAL TRIAL IMAGING MARKET FOR ULTRASOUND, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. CLINICAL TRIAL IMAGING MARKET FOR POSITRON EMISSION TOMOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. CLINICAL TRIAL IMAGING MARKET FOR X-RAY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. CLINICAL TRIAL IMAGING MARKET FOR ECHOCARDIOGRAPHY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. CLINICAL TRIAL IMAGING MARKET FOR OTHER MODALITIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. CLINICAL TRIAL IMAGING MARKET SEGMENTATION, BY BY END-USER
  • FIGURE 23. CLINICAL TRIAL IMAGING MARKET FOR PHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. CLINICAL TRIAL IMAGING MARKET FOR BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. CLINICAL TRIAL IMAGING MARKET FOR MEDICAL DEVICE MANUFACTURERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. CLINICAL TRIAL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. CLINICAL TRIAL IMAGING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 28. CLINICAL TRIAL IMAGING MARKET FOR OTHER END-USERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 29. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 30. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 31. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 32. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 33. COMPETITIVE DASHBOARD
  • FIGURE 34. COMPETITIVE HEATMAP: CLINICAL TRIAL IMAGING MARKET
  • FIGURE 35. TOP PLAYER POSITIONING, 2024
  • FIGURE 36. PAREXEL INTERNATIONAL CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. PAREXEL INTERNATIONAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. PAREXEL INTERNATIONAL CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. BIOMEDICAL SYSTEMS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. BIOMEDICAL SYSTEMS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. BIOMEDICAL SYSTEMS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. BIOTELEMETRY, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. BIOTELEMETRY, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. BIOTELEMETRY, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. CARDIOVASCULAR IMAGING TECHNOLOGIES LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. CARDIOVASCULAR IMAGING TECHNOLOGIES LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. CARDIOVASCULAR IMAGING TECHNOLOGIES LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. INTRINSIC IMAGING LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. INTRINSIC IMAGING LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. INTRINSIC IMAGING LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. RADIANT SAGE LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. RADIANT SAGE LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. RADIANT SAGE LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. WORLDCARE CLINICAL, LLC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. WORLDCARE CLINICAL, LLC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. WORLDCARE CLINICAL, LLC.: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Clinical Trial Imaging Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved